Liver Disease


Sofeni

Sofosbuvir, 400mg

sofeni

Sofeni (Sofosbuvir) is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of genotype 1, 2, 3 or 4 chronic hepatitis C virus (HCV) infection as a component of a combination antiviral treatment regimen.

Dactinna

Daclatasvir,90mg

dactinna

Dactinna (Daclatasvir) is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir for the treatment of chronic HCV infection.

Liveni

Ledipasvir/Sofosbuvir,90mg/400mg

liveni

Liveni (ledipasvir/sofosbuvir )is a fixed-dose combination tablet, contains ledipasvir/sofosbuvir 90 mg/400 mg for the treatment of chronic HCV infection.

Telarfe

Tenofovir Alafenamide Fumarate,25mg

telarfe

Telarfe (Tenofovir alafenamide ) is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir. It is used in the treatment of Chronic hepatitis B virus infection in adults with compensated liver disease.

Gienoe

Velpatasvir 100mg, Sofosbuvir 400mg

Gienoe

Gienoe Sofosbuvir + Velpatasvir is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection

– without cirrhosis or with compensated cirrhosis
– with decompensated cirrhosis for use in combination with ribavirin